Free Trial

Akari Therapeutics (AKTX) SEC Filings & 10K Form

Akari Therapeutics logo
$0.76 -0.05 (-5.82%)
Closing price 08/29/2025 03:57 PM Eastern
Extended Trading
$0.78 +0.02 (+2.50%)
As of 08/29/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Akari Therapeutics SEC Filings

DateFilerForm TypeView
08/29/2025
4:15 PM
Akari Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/29/2025
3:55 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
4:01 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2025
4:00 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025
7:00 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025
11:15 PM
Akari Therapeutics (Filer)
Form EFFECT
07/29/2025
4:21 PM
Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/29/2025
4:25 PM
Akari Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/01/2025
4:30 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:00 PM
Akari Therapeutics (Filer)
Form PRE 14A
05/15/2025
7:58 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:15 PM
Akari Therapeutics (Filer)
Form EFFECT
05/06/2025
4:23 PM
Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/29/2025
4:00 PM
Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:00 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
3:33 PM
Akari Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM
Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:50 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:10 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4/A
01/13/2025
7:00 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:05 AM
Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:05 AM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
4:30 PM
Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad)

Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel

12/30/2024
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM
Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2024
3:30 PM
Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:30 PM
Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:30 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:00 PM
Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
Form SC 13D/A
12/03/2024
4:48 PM
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:50 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:30 PM
Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM
Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM
Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
3:48 PM
Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
7:02 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:27 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:00 AM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
5:00 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:51 AM
Akari Therapeutics (Subject)
Form 425
10/14/2024
11:15 PM
Akari Therapeutics (Filer)
Form EFFECT
10/11/2024
3:52 PM
Akari Therapeutics (Filer)
Form 424B3
10/09/2024
3:27 PM
Akari Therapeutics (Filer)
Form S-4/A
10/04/2024
3:30 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:34 PM
Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:43 AM
Akari Therapeutics (Filer)
Form S-4/A
09/18/2024
3:34 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:36 PM
Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
3:40 PM
Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM
Akari Therapeutics (Filer)
Form EFFECT
09/13/2024
4:30 PM
Akari Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/06/2024
4:23 PM
Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/06/2024
4:07 PM
Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKTX) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners